Peptide Drugs advanced
GLP-1 and Alzheimers: Oligopeptide Research Reference
Investigation of effects on amyloid pathology, tau phosphorylation, and cognitive decline. This peptide or oligopeptide is studied for its biological activit...
By Encyclopeptide Editorial | 1 min read
glp1 neuroprotection alzheimers
Overview
Investigation of effects on amyloid pathology, tau phosphorylation, and cognitive decline.
Structure
| Property | Value |
|---|---|
| Name | GLP-1 and Alzheimers |
Mechanism of Action
GLP-1 agonists reduce amyloid-beta and tau pathology in animal models of Alzheimer disease.
References
- Wikipept Peptide Database
- Primary literature (see individual entries)
Chemical Identity
| Property | Value |
|---|---|
| Name | GLP-1 and Alzheimers |
| Category | Peptide Drugs |
Test Your Knowledge
Reinforce what you learned about GLP-1 and Alzheimers: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept